Estados Unidos

Mercado internacional de ações

Cadastro completo das bolsas americanas, histórico de preços, demonstrações financeiras, indicadores, rentabilidade, crescimento, endividamento, qualidade, mercado e dividendos.

Ações ordinárias, common stocks e ADRs/ADSs ativos; ETFs, units, warrants, direitos e preferenciais ficam fora desta aba.

Explorar REITs americanos

5.660

ações no escopo

5.646

ligadas à SEC

5.651

com preços

5.119

com fundamentos

18/09/2026

última cotação

SEC como fonte principal

Identidade regulatória, demonstrações anuais e trimestrais e dividendos declarados vêm do EDGAR/XBRL.

Cadastro oficial

Nasdaq Trader cobre Nasdaq, NYSE, NYSE American, NYSE Arca, Cboe e IEX.

Proveniência explícita

A janela pública da Nasdaq tem prioridade; Yahoo Finance completa o período anterior sem ser rotulado como oficial.

Destaques do mercado

Ranking de Stocks

Listas objetivas calculadas sobre todo o universo de ações dos EUA, com preços de mercado e fundamentos SEC.

Top 5

Todas as ações

502 resultados

Ação	Bolsa	Preço	Valor de mercado	P/L

EVOEvotec SE - American Depositary Shares each representing 1/2 of one ordinary share	NASDAQ	US$ 1,73	US$ 307,17 mi	—	0,32x	-20,59%	—	Preço 11/09/2026 SEC 31/12/2024
PREPrenetics Global Limited - Class A Ordinary Share	NASDAQ	US$ 23,47	US$ 304,75 mi	—	1,78x	-29,07%	—	Preço 11/09/2026 SEC 31/12/2024
VNDAVanda Pharmaceuticals Inc. - Common Stock	NASDAQ	US$ 5,09	US$ 299,95 mi	—	0,92x	-67,38%	—	Preço 11/09/2026 SEC 31/12/2025
BIOABioAge Labs, Inc. - Common Stock	NASDAQ	US$ 8,06	US$ 289,62 mi	—	1,06x	-29,63%	—	Preço 18/09/2026 SEC 31/12/2025
ALTAltimmune, Inc. - Common Stock	NASDAQ	US$ 3,25	US$ 286,34 mi	—	1,27x	-39,17%	—	Preço 18/09/2026 SEC 31/12/2025
RMTIRockwell Medical, Inc. - Common Stock	NASDAQ	US$ 7,94	US$ 285,64 mi	—	7,72x	-14,37%	—	Preço 14/09/2026 SEC 31/12/2025
TRDAEntrada Therapeutics, Inc. - Common Stock	NASDAQ	US$ 6,80	US$ 281,33 mi	—	0,92x	-46,96%	—	Preço 11/09/2026 SEC 31/12/2025
HELPCybin Inc. - Common Stock	NASDAQ	US$ 12,97	US$ 280,17 mi	—	1,18x	-47,70%	—	Preço 11/09/2026 SEC 31/03/2025
ASMBAssembly Biosciences, Inc. - Common Stock	NASDAQ	US$ 24,97	US$ 279,94 mi	—	1,35x	-2,96%	—	Preço 18/09/2026 SEC 31/12/2025
FHTXFoghorn Therapeutics Inc. - Common Stock	NASDAQ	US$ 4,42	US$ 278,38 mi	—	-2,57x	68,46%	—	Preço 11/09/2026 SEC 31/12/2025
DRUGBright Minds Biosciences Inc. - common stock	NASDAQ	US$ 60,22	US$ 272,44 mi	—	49,21x	-50,61%	—	Preço 15/09/2026 SEC 30/09/2024
ACIUAC Immune SA - Common Stock	NASDAQ	US$ 2,63	US$ 267,58 mi	—	5,96x	-156,95%	—	Preço 18/09/2026 SEC 31/12/2025
LABStandard BioTools Inc. - Common Stock	NASDAQ	US$ 0,70	US$ 265,46 mi	—	0,63x	-17,65%	—	Preço 14/09/2026 SEC 31/12/2025
BCYCBicycle Therapeutics plc - American Depositary Shares	NASDAQ	US$ 3,65	US$ 252,87 mi	—	0,41x	-35,90%	0,00%	Preço 18/09/2026 SEC 31/12/2025
MGNXMacroGenics, Inc. - Common Stock	NASDAQ	US$ 4,00	US$ 252,62 mi	—	4,54x	-134,23%	—	Preço 11/09/2026 SEC 31/12/2025
ZNTLZentalis Pharmaceuticals, Inc. - common stock	NASDAQ	US$ 3,51	US$ 252,26 mi	—	1,17x	-63,39%	—	Preço 11/09/2026 SEC 31/12/2025
WHWKWhitehawk Therapeutics, Inc. - Common Stock	NASDAQ	US$ 4,07	US$ 251,88 mi	—	1,85x	-15,11%	—	Preço 14/09/2026 SEC 31/12/2025
NATRNature's Sunshine Products, Inc. - Common Stock	NASDAQ	US$ 13,55	US$ 250,24 mi	12,78x	1,55x	12,08%	—	Preço 11/09/2026 SEC 31/12/2025
GALTGalectin Therapeutics Inc. - Common Stock	NASDAQ	US$ 3,91	US$ 249,86 mi	—	-1,95x	24,11%	—	Preço 11/09/2026 SEC 31/12/2025
INCRIntercure Ltd. - ordinary shares	NASDAQ	US$ 5,16	US$ 243,36 mi	—	0,61x	-18,30%	—	Preço 11/09/2026 SEC 31/12/2024
SCYXSCYNEXIS, Inc. - Common Stock	NASDAQ	US$ 4,84	US$ 241,68 mi	—	4,89x	-17,44%	—	Preço 11/09/2026 SEC 31/12/2025
AKBAAkebia Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,92	US$ 235,48 mi	—	7,22x	-16,39%	—	Preço 18/09/2026 SEC 31/12/2025
ENLVEnlivex Ltd. - Ordinary Shares	NASDAQ	US$ 0,96	US$ 227,89 mi	0,04x	0,12x	63,85%	—	Preço 11/09/2026 SEC 31/12/2025
ELDNEledon Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 2,78	US$ 227,50 mi	—	2,81x	-56,26%	—	Preço 11/09/2026 SEC 31/12/2025
MREOMereo BioPharma Group plc - American Depositary Shares	NASDAQ	US$ 0,28	US$ 223,19 mi	—	5,45x	-102,35%	—	Preço 11/09/2026 SEC 31/12/2025
AVTXAvalo Therapeutics, Inc. - Common Stock	NASDAQ	US$ 16,57	US$ 222,12 mi	—	2,67x	-94,23%	—	Preço 18/09/2026 SEC 31/12/2025
NKTXNkarta, Inc. - Common Stock	NASDAQ	US$ 2,97	US$ 220,12 mi	—	0,70x	-33,33%	0,00%	Preço 14/09/2026 SEC 31/12/2025
SIGASIGA Technologies Inc. - Common Stock	NASDAQ	US$ 3,03	US$ 217,76 mi	9,47x	1,10x	11,71%	19,80%	Preço 11/09/2026 SEC 31/12/2025
PYXSPyxis Oncology, Inc. - Common Stock	NASDAQ	US$ 3,47	US$ 215,64 mi	—	4,04x	-149,08%	—	Preço 14/09/2026 SEC 31/12/2025
CATXPerspective Therapeutics, Inc. Common Stock	NYSE American	US$ 2,88	US$ 212,58 mi	—	1,03x	-49,81%	—	Preço 18/09/2026 SEC 31/12/2025
RNACCartesian Therapeutics, Inc. - Common Stock	NASDAQ	US$ 8,13	US$ 211,16 mi	—	-1,67x	103,22%	—	Preço 14/09/2026 SEC 31/12/2025
GLSIGreenwich LifeSciences, Inc. - Common stock	NASDAQ	US$ 15,45	US$ 209,12 mi	—	592,03x	-5.480,55%	—	Preço 11/09/2026 SEC 31/12/2025
LYELLyell Immunopharma, Inc. - Common Stock	NASDAQ	US$ 11,96	US$ 204,43 mi	—	0,82x	-110,57%	—	Preço 11/09/2026 SEC 31/12/2025
NRSNNeuroSense Therapeutics Ltd. - Ordinary Shares	NASDAQ	US$ 6,18	US$ 201,20 mi	—	-128,98x	713,14%	—	Preço 14/09/2026 SEC 31/12/2025
ORMPOramed Pharmaceuticals Inc. - Common Stock	NASDAQ	US$ 4,66	US$ 197,67 mi	3,11x	0,99x	32,07%	5,36%	Preço 11/09/2026 SEC 31/12/2025
ADAGAdagene Inc. - ADS, each representing 1.25 ordinary shares	NASDAQ	US$ 3,31	US$ 196,06 mi	—	5,55x	-49,82%	—	Preço 18/09/2026 SEC 31/12/2025
PRQRProQR Therapeutics N.V. - Ordinary Shares	NASDAQ	US$ 1,86	US$ 195,97 mi	—	3,97x	-85,44%	—	Preço 11/09/2026 SEC 31/12/2025
ORGOOrganogenesis Holdings Inc. - Class A	NASDAQ	US$ 1,49	US$ 194,07 mi	9,93x	0,65x	12,34%	—	Preço 11/09/2026 SEC 31/12/2025
IMRXImmuneering Corporation - Class A Common Stock	NASDAQ	US$ 4,27	US$ 187,93 mi	—	0,86x	-25,64%	—	Preço 11/09/2026 SEC 31/12/2025
SLGLSol-Gel Technologies Ltd. - Ordinary Shares	NASDAQ	US$ 65,94	US$ 183,72 mi	—	8,05x	-26,86%	—	Preço 11/09/2026 SEC 31/12/2025
DERMJourney Medical Corporation - Common Stock	NASDAQ	US$ 7,36	US$ 180,31 mi	—	5,66x	-35,89%	—	Preço 15/09/2026 SEC 31/12/2025
RLMDRelmada Therapeutics, Inc. - Common Stock	NASDAQ	US$ 4,47	US$ 176,67 mi	—	2,04x	-66,33%	—	Preço 14/09/2026 SEC 31/12/2025
NGENNervGen Pharma Corp. - Common stock	NASDAQ	US$ 2,19	US$ 174,03 mi	—	50,05x	-1.268,86%	—	Preço 11/09/2026 SEC 31/12/2025
CYPHCypherpunk Technologies Inc. - Common Stock	NASDAQ	US$ 2,22	US$ 156,89 mi	31,71x	1,02x	3,14%	—	Preço 15/09/2026 SEC 31/12/2025
ANTXAN2 Therapeutics, Inc. - Common Stock	NASDAQ	US$ 5,05	US$ 152,59 mi	—	2,88x	-66,29%	—	Preço 18/09/2026 SEC 31/12/2025
MENSJyong Biotech Ltd. - Ordinary shares	NASDAQ	US$ 1,99	US$ 151,30 mi	—	-6,07x	18,75%	—	Preço 11/09/2026 SEC 31/12/2025
IFRXInflaRx N.V. - Common Stock	NASDAQ	US$ 2,09	US$ 151,09 mi	—	3,64x	-109,81%	—	Preço 11/09/2026 SEC 31/12/2025
MSLESatellos Bioscience Inc. - Common Stock	NASDAQ	US$ 9,75	US$ 150,72 mi	—	5,42x	-89,52%	—	Preço 11/09/2026 SEC 31/12/2025
BBOTBridgeBio Oncology Therapeutics, Inc. - Common Stock	NASDAQ	US$ 4,77	US$ 148,56 mi	—	0,36x	-32,61%	—	Preço 18/09/2026 SEC 31/12/2025
LFCRLifecore Biomedical, Inc. - Common Stock	NASDAQ	US$ 4,06	US$ 141,44 mi	—	105,87x	-2.897,98%	—	Preço 14/09/2026 SEC 25/05/2025
QTTBQ32 Bio Inc. - Common Stock	NASDAQ	US$ 11,09	US$ 136,57 mi	4,58x	3,25x	70,98%	—	Preço 14/09/2026 SEC 31/12/2025
ADCTADC Therapeutics SA Common Shares	NYSE	US$ 1,05	US$ 133,42 mi	—	-0,72x	76,75%	—	Preço 18/09/2026 SEC 31/12/2025
KRROKorro Bio, Inc. - Common Stock	NASDAQ	US$ 13,81	US$ 129,75 mi	—	2,52x	-227,96%	—	Preço 11/09/2026 SEC 31/12/2025
CAMPCAMP4 Therapeutics Corporation - Common Stock	NASDAQ	US$ 4,24	US$ 128,81 mi	—	2,70x	-168,55%	0,00%	Preço 18/09/2026 SEC 31/12/2025
PEPGPepGen Inc. - Common Stock	NASDAQ	US$ 2,98	US$ 125,82 mi	—	0,85x	-60,81%	—	Preço 11/09/2026 SEC 31/12/2025
IBIOiBio, Inc. - Common Stock	NASDAQ	US$ 1,21	US$ 125,39 mi	—	1,46x	-38,55%	—	Preço 11/09/2026 SEC 30/06/2026
EQEquillium, Inc. - Common Stock	NASDAQ	US$ 2,11	US$ 120,91 mi	—	4,23x	-78,32%	—	Preço 11/09/2026 SEC 31/12/2025
OGIOrganigram Global Inc. - Common Shares	NASDAQ	US$ 1,07	US$ 116,19 mi	—	0,38x	-14,85%	—	Preço 14/09/2026 SEC 30/09/2024
MPLTMapLight Therapeutics, Inc. - Common Stock	NASDAQ	US$ 13,00	US$ 112,85 mi	—	0,25x	-35,16%	—	Preço 11/09/2026 SEC 31/12/2025
IXHLIncannex Healthcare Inc. - Common Stock	NASDAQ	US$ 3,26	US$ 112,32 mi	—	8,39x	-350,18%	—	Preço 11/09/2026 SEC 30/06/2025
CURXCuranex Pharmaceuticals Inc - Common Stock	NASDAQ	US$ 4,29	US$ 109,38 mi	—	9,75x	-37,66%	—	Preço 15/09/2026 SEC 31/12/2025
TLSATiziana Life Sciences Ltd - Common Shares	NASDAQ	US$ 0,96	US$ 107,00 mi	—	27,19x	-301,40%	—	Preço 11/09/2026 SEC 31/12/2024
JUNSJupiter Neurosciences, Inc. - Common Stock	NASDAQ	US$ 3,05	US$ 105,62 mi	—	-57,66x	471,92%	—	Preço 11/09/2026 SEC 31/12/2025
AARDAardvark Therapeutics, Inc. - Common Stock	NASDAQ	US$ 5,38	US$ 105,58 mi	—	0,99x	-54,01%	—	Preço 18/09/2026 SEC 31/12/2025
CPIXCumberland Pharmaceuticals Inc. - Common Stock	NASDAQ	US$ 6,98	US$ 103,69 mi	—	4,22x	-11,56%	—	Preço 16/09/2026 SEC 31/12/2025
KRSAKorsana Biosciences, Inc. - Common Stock	NASDAQ	US$ 31,91	US$ 101,49 mi	—	11,17x	-38,83%	—	Preço 11/09/2026 SEC 31/12/2025
TNXPTonix Pharmaceuticals Holding Corp. - Common Stock	NASDAQ	US$ 11,87	US$ 101,03 mi	—	0,41x	-50,59%	—	Preço 11/09/2026 SEC 31/12/2025
HURATuHURA Biosciences, Inc. - Common Stock	NASDAQ	US$ 2,09	US$ 99,98 mi	—	4,78x	-143,57%	—	Preço 14/09/2026 SEC 31/12/2025
CRBPCorbus Pharmaceuticals Holdings, Inc. - Common Stock	NASDAQ	US$ 7,26	US$ 96,68 mi	—	0,66x	-53,24%	—	Preço 16/09/2026 SEC 31/12/2025
BMEABiomea Fusion, Inc. - Common Stock	NASDAQ	US$ 1,83	US$ 95,58 mi	—	3,23x	-209,11%	—	Preço 18/09/2026 SEC 31/12/2025
RLYBRallybio Corporation - Common Stock	NASDAQ	US$ 16,55	US$ 93,16 mi	—	1,61x	-15,49%	—	Preço 14/09/2026 SEC 31/12/2025
GNLXGenelux Corporation - Common Stock	NASDAQ	US$ 2,49	US$ 92,57 mi	—	8,02x	-278,46%	—	Preço 11/09/2026 SEC 31/12/2025
PLYXPolaryx Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,01	US$ 91,30 mi	—	20,00x	-196,82%	—	Preço 11/09/2026 SEC 31/12/2025
ALXOALX Oncology Holdings Inc. - Common Stock	NASDAQ	US$ 1,70	US$ 91,22 mi	—	3,51x	-391,42%	—	Preço 18/09/2026 SEC 31/12/2025
MNOVMediciNova, Inc. - Common Stock	NASDAQ	US$ 1,81	US$ 88,80 mi	—	2,14x	-28,85%	—	Preço 11/09/2026 SEC 31/12/2025
UNCYUnicycive Therapeutics, Inc. - Common Stock	NASDAQ	US$ 5,29	US$ 84,04 mi	—	2,78x	-87,94%	—	Preço 11/09/2026 SEC 31/12/2025
ALDXAldeyra Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,36	US$ 81,68 mi	—	1,85x	-76,49%	—	Preço 18/09/2026 SEC 31/12/2025
SKYESkye Bioscience, Inc. - Common Stock	NASDAQ	US$ 2,04	US$ 80,91 mi	—	4,04x	-279,29%	—	Preço 11/09/2026 SEC 31/12/2025
LFVNLifevantage Corporation - Common Stock	NASDAQ	US$ 6,17	US$ 78,37 mi	15,43x	2,33x	15,10%	3,00%	Preço 11/09/2026 SEC 30/06/2026
COYACoya Therapeutics, Inc. - Common Stock	NASDAQ	US$ 4,46	US$ 74,62 mi	—	1,73x	-49,33%	—	Preço 16/09/2026 SEC 31/12/2025
MANEVeradermics, Incorporated Common Stock	NYSE	US$ 98,97	US$ 73,73 mi	—	-0,61x	57,84%	—	Preço 11/09/2026 SEC 31/12/2025
PMVPPMV Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 1,40	US$ 73,56 mi	—	0,70x	-74,24%	—	Preço 11/09/2026 SEC 31/12/2025
ZYBTZhengye Biotechnology Holding Limited - Class A Ordinary Shares	NASDAQ	US$ 1,55	US$ 73,46 mi	—	0,24x	-22,75%	—	Preço 11/09/2026 SEC 31/12/2025
TENXTenax Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,86	US$ 72,94 mi	—	0,75x	-54,19%	—	Preço 14/09/2026 SEC 31/12/2025
LEXXLexaria Bioscience Corp. - Common Stock	NASDAQ	US$ 4,01	US$ 72,08 mi	—	27,70x	-457,28%	—	Preço 14/09/2026 SEC 31/08/2025
FBLGFibroBiologics, Inc. - Common Stock	NASDAQ	US$ 1,61	US$ 71,90 mi	—	11,68x	-302,89%	—	Preço 11/09/2026 SEC 31/12/2025
PLRXPliant Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,17	US$ 71,80 mi	—	0,40x	-82,42%	0,00%	Preço 11/09/2026 SEC 31/12/2025
ONCYOncolytics Biotech Inc. - Common Stock	NASDAQ	US$ 0,75	US$ 71,46 mi	—	-18,81x	757,02%	—	Preço 11/09/2026 SEC 31/12/2025
NTHINeOnc Technologies Holdings, Inc. - Common Stock	NASDAQ	US$ 3,68	US$ 71,39 mi	—	-4,08x	354,96%	—	Preço 11/09/2026 SEC 31/12/2025
CNTBConnect Biopharma Holdings Limited - Ordinary Shares	NASDAQ	US$ 1,28	US$ 71,24 mi	—	1,70x	-132,16%	—	Preço 18/09/2026 SEC 31/12/2025
ACRVAcrivon Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,85	US$ 71,24 mi	—	0,63x	-69,24%	—	Preço 18/09/2026 SEC 31/12/2025
FBIOFortress Biotech, Inc. - Common Stock	NASDAQ	US$ 2,52	US$ 70,31 mi	—	1,13x	10,96%	—	Preço 11/09/2026 SEC 31/12/2025
XBITXBiotech Inc. - Common Stock	NASDAQ	US$ 2,19	US$ 66,77 mi	—	0,48x	-32,45%	—	Preço 11/09/2026 SEC 31/12/2025
SPROSpero Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,13	US$ 66,71 mi	7,53x	1,13x	14,52%	—	Preço 11/09/2026 SEC 31/12/2025
EVMNEvommune, Inc. Common Stock	NYSE	US$ 10,54	US$ 64,68 mi	—	0,31x	-33,50%	—	Preço 11/09/2026 SEC 31/12/2025
RFLRafael Holdings, Inc. Class B Common Stock	NYSE	US$ 2,19	US$ 64,43 mi	—	0,66x	-31,03%	—	Preço 14/09/2026 SEC 31/07/2025
ACETAdicet Bio, Inc. - Common Stock	NASDAQ	US$ 9,18	US$ 63,26 mi	—	0,40x	-73,36%	—	Preço 18/09/2026 SEC 31/12/2025
BOLDBoundless Bio, Inc. - Common Stock	NASDAQ	US$ 2,81	US$ 62,83 mi	—	0,64x	-58,99%	—	Preço 18/09/2026 SEC 31/12/2025
CTORCitius Oncology, Inc. - Common Stock	NASDAQ	US$ 0,86	US$ 62,72 mi	—	1,40x	-55,19%	—	Preço 15/09/2026 SEC 30/09/2025
RNXTRenovoRx, Inc. - Common Stock	NASDAQ	US$ 1,76	US$ 62,19 mi	—	11,47x	-205,98%	—	Preço 11/09/2026 SEC 31/12/2025

Mercado internacional de ações

Ranking de Stocks

Mais populares

Todas as ações

Maiores lucros

Maiores ROEs

Maiores altas